Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 29 studies | 27% ± 10% | |
pericyte | 29 studies | 28% ± 10% | |
smooth muscle cell | 29 studies | 36% ± 12% | |
myofibroblast cell | 14 studies | 33% ± 12% | |
endothelial cell | 8 studies | 31% ± 11% | |
connective tissue cell | 7 studies | 29% ± 11% | |
type I pneumocyte | 6 studies | 18% ± 2% | |
cardiac muscle cell | 5 studies | 21% ± 3% | |
adipocyte | 4 studies | 20% ± 3% | |
epithelial cell | 3 studies | 18% ± 2% | |
Schwann cell | 3 studies | 22% ± 1% | |
melanocyte | 3 studies | 36% ± 20% | |
muscle cell | 3 studies | 44% ± 19% |
Insufficient scRNA-seq data for expression of KANK2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 22233.23 | 242 / 245 | 99% | 56.04 | 499 / 502 |
breast | 100% | 15353.20 | 458 / 459 | 96% | 35.64 | 1077 / 1118 |
thymus | 99% | 11694.64 | 646 / 653 | 97% | 73.21 | 587 / 605 |
ovary | 100% | 29427.87 | 180 / 180 | 95% | 32.78 | 407 / 430 |
uterus | 99% | 52229.59 | 169 / 170 | 93% | 70.87 | 429 / 459 |
lung | 100% | 20150.38 | 576 / 578 | 92% | 30.83 | 1057 / 1155 |
bladder | 100% | 36979.57 | 21 / 21 | 87% | 27.76 | 440 / 504 |
intestine | 91% | 37654.59 | 877 / 966 | 94% | 25.95 | 497 / 527 |
adrenal gland | 87% | 7847.57 | 224 / 258 | 93% | 30.95 | 215 / 230 |
esophagus | 87% | 37580.69 | 1261 / 1445 | 89% | 31.52 | 163 / 183 |
skin | 74% | 8633.98 | 1340 / 1809 | 99% | 78.55 | 468 / 472 |
stomach | 79% | 15241.74 | 284 / 359 | 93% | 36.85 | 266 / 286 |
kidney | 70% | 6265.31 | 62 / 89 | 98% | 55.01 | 884 / 901 |
liver | 28% | 1745.94 | 64 / 226 | 93% | 32.13 | 377 / 406 |
pancreas | 10% | 572.79 | 32 / 328 | 97% | 46.24 | 172 / 178 |
blood vessel | 100% | 43283.92 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 30.30 | 1 / 1 |
adipose | 100% | 20391.15 | 1203 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 83.76 | 79 / 80 |
heart | 96% | 18013.14 | 824 / 861 | 0% | 0 | 0 / 0 |
brain | 2% | 139.28 | 59 / 2642 | 91% | 28.72 | 645 / 705 |
tonsil | 0% | 0 | 0 / 0 | 91% | 17.79 | 41 / 45 |
spleen | 87% | 8359.59 | 210 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 45% | 7.40 | 13 / 29 |
muscle | 39% | 2969.44 | 311 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 5.02 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_2000134 | Biological process | negative regulation of G1/S transition of mitotic cell cycle |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0030837 | Biological process | negative regulation of actin filament polymerization |
GO_0070563 | Biological process | negative regulation of vitamin D receptor signaling pathway |
GO_0072073 | Biological process | kidney epithelium development |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0035023 | Biological process | regulation of Rho protein signal transduction |
GO_0043069 | Biological process | negative regulation of programmed cell death |
GO_0033147 | Biological process | negative regulation of intracellular estrogen receptor signaling pathway |
GO_0090521 | Biological process | podocyte cell migration |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0005515 | Molecular function | protein binding |
Gene name | KANK2 |
Protein name | KN motif and ankyrin repeat domain-containing protein 2 (Ankyrin repeat domain-containing protein 25) (Matrix-remodeling-associated protein 3) (SRC-1-interacting protein) (SIP) (SRC-interacting protein) (SRC1-interacting protein) KN motif and ankyrin repeat domains 2 |
Synonyms | KIAA1518 ANKRD25 SIP MXRA3 |
Description | FUNCTION: Involved in transcription regulation by sequestering in the cytoplasm nuclear receptor coactivators such as NCOA1, NCOA2 and NCOA3 . Involved in regulation of caspase-independent apoptosis by sequestering the proapoptotic factor AIFM1 in mitochondria . Pro-apoptotic stimuli can induce its proteasomal degradation allowing the translocation of AIFM1 to the nucleus to induce apoptosis . Involved in the negative control of vitamin D receptor signaling pathway . Involved in actin stress fibers formation through its interaction with ARHGDIA and the regulation of the Rho signaling pathway . May thereby play a role in cell adhesion and migration, regulating for instance podocytes migration during development of the kidney . Through the Rho signaling pathway may also regulate cell proliferation (By similarity). . |
Accessions | K7ES05 ENST00000588787.5 K7ERU2 K7EIU4 ENST00000590685.5 ENST00000588724.5 ENST00000586659.6 [Q63ZY3-1] ENST00000589894.1 [Q63ZY3-3] ENST00000589359.5 [Q63ZY3-2] ENST00000592675.1 K7EL48 Q63ZY3 |